AbstractHIVINTEREST 2020Cost-utility analysis of dolutegravir- versus efavirenz 400mg-based regimen for the initial treatment of HIV-infected patients in Cameroon: 96-week results from the NAMSAL ANRS 12313 trialView Abstract
AbstractHIVINTEREST 2020What shapes resilience among people living with HIV? A multi-country analysis of data from the PLHIV Stigma Index 2.0View Abstract
SlidesetHIVINTEREST 2020What Shapes Resilience Among People Living with HIV? A Multi-Country Analysis of... - Stella KentusiView Slideset
SlidesetHIVINTEREST 2020Cost-Utility Analysis of Dolutegravir-Versus Efavirenz 400mg- Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon: 96-week Results from the NAMSAL ANRS 12313 Trial - Marwan al Qays BousmahView Slideset
SlidesetHIVINTEREST 2020The Frequency and Yield of Cryptococcal Antigen Screening among Newly Diagnosed and Anti-Retroviral Therapy Experienced HIV Patients in Rural Uganda - Joseph BalukuView Slideset
SlidesetHIVINTEREST 2020The Effect of Hazardous Drinking on Key HIV Outcomes among HIV-Positive Men: Results from Six Population-Based HIV Impact Assessments Completed in Sub-Saharan Africa (2015-2018) - Gregory ChangView Slideset
VideoHIVINTEREST 2020Transcriptional Analysis of Lymph Node Derived Follicular CD4 T Cells Reveal Novel Phenotypic Markers and Functions of T Follicular Regulatory (TFR) Cells - Bongiwe MahloboView Video
VideoHIVINTEREST 2020Short-Cycle Therapy in HIV-Infected Adults: 4 days on / 3 days off with Combinations Containing Rilpivirine - Dora LuiseView Video
VideoHIVINTEREST 2020Positive Effects of Intensified Preventive Calls/Home Visits on Early Retention Among Adults Newly Initiated on Antiretroviral Therapy in Zambézia Province, Mozambique - José TiqueView Video
VideoHIVINTEREST 2020Alarming Burden of Dual-Class HIV-1 Drug Resistance Among Adolescents Calls for Innovative Antiretroviral Strategies: Baseline Findings from the Ready-Study (EDCTP TMA 1027) - Armanda NangmoView Video
